Adiposity profile in the dwarf rat: An unusually lean model of profound growth hormone deficiency

American Journal of Physiology - Endocrinology and Metabolism

Volumn 292, Issue 5, 2007, Pages

  Davies, Jeffrey S ^a   Gevers, Evelien F ^b   Stevenson, Amy E ^a   Coschigano, Karen T ^c   El Kasti, Muna M ^a   Bull, Melanie J ^a   Elford, Carole ^d   Evans, Bronwen A J ^d   Kopchick, John J ^c,e   Wells, Timothy ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c OHIO UNIVERSITY   (United States)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e OHIO UNIVERSITY   (United States)

Author keywords

Adipose tissue; Bone marrow fat; Dwarfism; Leptin

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; LEPTIN; SOMATOMEDIN C;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CONTROLLED STUDY; DIET; DWARFISM; FEEDING; FOOD INTAKE; GROWTH HORMONE DEFICIENCY; HORMONE DETERMINATION; NONHUMAN; OBESITY; ONTOGENY; PRIORITY JOURNAL; RAT;

ABDOMINAL FAT; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BODY WEIGHT; COHORT STUDIES; DWARFISM, PITUITARY; EATING; FEMALE; FOOD ADDITIVES; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RATS; SODIUM GLUTAMATE; TIBIA;

EID: 34247552777     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00417.2006     Document Type: Article

References (39)

1. Acs Z, Antoni FA, Makara GB. Corticoliberin and somatoliberin activity in the pituitary stalk median eminence of rats after neonatal treatment with monosodium glutamate. J Endocrinol 93: 239-245, 1982.
2. Bengtsson BÅ, Edén S, Lönn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tölli J, Sjöström L, Isaksson OG. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76: 309-317, 1993.
3. Berryman DE, List EO, Coschigano KT, Behar K, Kim JK, Kopchick JJ. Comparing adiposity profiles in three models with altered GH signaling. Growth Horm IGF Res 14: 309-318, 2004.
4. Berryman DE, List EO, Kohn DT, Coschigano KT, Seeley RJ, Kopchick JJ. Effect of growth hormone on susceptibility to diet-induced obesity. Endocrinology 147: 2801-2808, 2006.
5. Bloch B, Ling N, Benoit R, Wehrenberg WB, Guillemin R. Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence. Nature 307: 272-273, 1984.
6. Bunyan J, Murrell EA, Shah PP. The induction of obesity in rodents by means of monosodium glutamate. Br J Nutr 35: 25-39, 1976.
7. Carmignac DF, Wells T, Carlsson LM, Clark RG, Robinson IC. Growth hormone binding protein in normal and GH deficient dwarf rats. J Endocrinol 135: 447-457, 1992.
8. Charlton HM, Clark RG, Robinson IC, Goff AE, Cox BS, Bugnon C, Bloch BA. Growth hormone-deficient dwarfism in the rat: a new mutation. J Endocrinol 119: 51-58, 1988.
9. Chen WY, Wight DC, Mehta BV, Wagner TE, Kopchick JJ. Glycine 119 of bovine growth hormone is critical for growth-promoting activity. Mol Endocrinol 5: 1845-1852, 1991.
10. Clark RG, Mortensen DL, Carlsson LM, Carlsson B, Carmignac D, Robinson IC. The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I. Endocrinology 137: 1904-1912, 1996.
11. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, Kopchick JJ. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144: 3799-3810, 2003.
12. Cummings DE, Merriam GR. Growth hormone therapy in adults. Annu Rev Med 54: 513-533, 2003.
13. Davies JS, Thompson NM, Christian HC, Pinilla L, Ebling FJ, Tena-Sempere M, Wells T. Hypothalamic expression of human growth hormone induces post-pubertal hypergonadotrophism in male transgenic growth retarded (Tgr) rats. J Neuroendocrinol 18: 719-731, 2006.
14. Donahue LR, Beamer WG. Growth hormone deficiency in "little" mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3) but does not affect IGFBP-2, -1 or -4. J Endocrinol 136: 91-104, 1993.
15. Egecioglu E, Bjursell M, Ljungberg A, Dickson SL, Kopchick JJ, Bergström G, Svensson L, Oscarsson J, Törnell J, Bohlooly-YM. Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice. Am J Physiol Endocrinol Metab 290: E317-E325, 2006.
16. Evans BA, Warner JT, Elford C, Evans SL, Laib A, Bains RK, Gregory JW, Wells T. Morphological determinants of femoral strength in growth hormone-deficient transgenic growth-retarded (Tgr) rats. J Bone Miner Res 18: 1308-1316, 2003.
17. Flavell DM, Wells T, Wells SE, Carmignac DF, Thomas GB, Robinson IC. Dominant dwarfism in transgenic rats by targeting human growth hormone (GH) to hypothalamic GH-releasing factor neurons. EMBO J 15: 3871-3879, 1996.
18. Flint DJ, Binart N, Boumard S, Kopchick JJ, Kelly P. Developmental aspects of adipose tissue in GH-receptor and prolactin receptor gene disrupted mice: site-specific effects upon proliferation, differentiation and hormone sensitivity. J Endocrinol 191: 101-111, 2006.
19. Flint DJ, Gardner MJ. Influence of growth hormone deficiency on growth, and body composition in rats: site-specific effects upon adipose tissue development. J Endocrinol 137: 203-213, 1993.
20. Gevers EF, Loveridge N, Robinson IC. Bone marrow adipocytes: a neglected target tissue for growth hormone. 1st Joint Symposium of the Growth Hormone and IGF Societies, Boston, MA. Growth Horm IGF Res 12: 249 (Abstract 077), 2002.
21. Gevers EF, Loveridge N, Robinson IC. Bone marrow adipocytes: a neglected target tissue for growth hormone. Endocrinology 143: 4065-4073, 2002.
22. Hansen LH, Madsen B, Teisner B, Nielsen JH, Billestrup N. Characterisation of the inhibitory effect of growth hormone on primary preadipocyte differentiation. Mol Endocrinol 12: 1140-1149, 1998.
23. Heurta-Ocampo I, Christian H, Thompson NM, El-Kasti MM, Wells T. The intermediate lactotroph: a morphologically distinct, ghrelin-responsive pituitary cell in the dwarf (dw/dw) rat. Endocrinology 146: 5012-5023, 2005.
24. Ishikawa M, Hiroi N, Kamioka T, Tanaka T, Tachibana T, Ishikawa H, Miyachi Y. Metabolic effects of 20kDa and 22kDa human growth hormones on adult male spontaneous dwarf rats. Eur J Endocrinol 145: 791-797, 2001.
25. Knapp JR, Chen WY, Turner ND, Byers FM, Kopchick JJ. Growth patterns and body composition of transgenic mice expressing mutated bovine somatotropin genes. J Anim Sci 72: 2812-2819, 1994.
26. Lall S, Tung LY, Ohlsson C, Jansson JO, Dickson SL. Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochem Biophys Res Commun 280: 132-138, 2001.
27. Legraverend C, Mode A, Wells T, Robinson IC, Gustafsson JÅ. Hepatic steroid hydroxylating enzymes are controlled by the sexually dimorphic pattern of growth hormone secretion in normal and dwarf rats. FASEB J 6: 711-718, 1992.
28. Masson P. Some histological methods. Trichrome stainings and their preliminary technique. Bull Int Assoc Med 12: 75, 1929.
29. Nemeroff CB, Lipton MA, Kizer JS. Models of neuroendocrine regulation: use of monosodium glutamate as an investigational tool. Dev Neurosci 1: 102-109, 1978.
30. Robertson K, Kopchick JJ, Liu JL. Growth hormone receptor gene deficiency causes delayed insulin responsiveness in skeletal muscles without affecting compensatory islet cell overgrowth in obese mice. Am J Physiol Endocrinol Metab 291: E491-E498, 2006.
31. Shadid S, Jensen MD. Effects of growth hormone administration in human obesity. Obes Res 11: 170-175, 2003.
32. Shang CA, Waters MJ. Constitutively active signal transducer and activator of transcription 5 can replace the requirement for growth hormone in adipogenesis of 3T3-F442A preadipocytes. Mol Endocrinol 17: 2494-2508, 2003.
33. Stevenson AE, Davies JS, Coschigano KT, Kopchick JJ, Wells T. Adiposity profiles in rodent models of profound and moderate GH deficiency (Abstract P3-97). Proceedings of the 87th Annual Meeting of the Endocrine Society, San Diego, CA, 2005.
34. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson IC, Wells T. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in-vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145: 234-242, 2004.
35. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 72: 51-59, 1991.
36. Wells T, Flavell DM, Wells SE, Carmignac DF, Robinson IC. Effects of GH secretagogues in the transgenic growth retarded (Tgr) rat. Endocrinology 138: 80-587, 1997.
37. Yang S, Bjorntorp P, Liu X, Eden S. Growth hormone treatment of hypophysectomised rats increases catecholamine induced lipolysis and the number of beta-adrenergic receptors in adipocytes: no differences in the effects of growth hormone on different fat depots. Obes Res 4: 471-478, 1996.
38. Yarwood SJ, Sale EM, Sale GJ, Houslay MD, Kilgour E, Anderson NG. Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signalling. J Biol Chem 274: 8662-8668, 1999.
39. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigano K, Wagner TE, Baumann G, Kopchick JJ. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94: 13215-13220, 1997.